Market closed
PMV Pharmaceuticals/$PMVP
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About PMV Pharmaceuticals
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Ticker
$PMVP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
63
Website
PMVP Metrics
BasicAdvanced
$81M
Market cap
-
P/E ratio
-$1.00
EPS
1.47
Beta
-
Dividend rate
Price and volume
Market cap
$81M
Beta
1.47
52-week high
$3.47
52-week low
$1.40
Average daily volume
209K
Financial strength
Current ratio
13.981
Quick ratio
13.481
Long term debt to equity
6.076
Total debt to equity
6.704
Management effectiveness
Return on assets (TTM)
-20.27%
Return on equity (TTM)
-23.63%
Valuation
Price to book
0.41
Price to tangible book (TTM)
0.41
Price to free cash flow (TTM)
-1.701
Growth
Earnings per share change (TTM)
-35.78%
3-year earnings per share growth (CAGR)
-3.33%
What the Analysts think about PMVP
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for PMV Pharmaceuticals stock.
PMVP Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PMVP Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for PMV Pharmaceuticals stock?
PMV Pharmaceuticals (PMVP) has a market cap of $81M as of December 13, 2024.
What is the P/E ratio for PMV Pharmaceuticals stock?
The price to earnings (P/E) ratio for PMV Pharmaceuticals (PMVP) stock is 0 as of December 13, 2024.
Does PMV Pharmaceuticals stock pay dividends?
No, PMV Pharmaceuticals (PMVP) stock does not pay dividends to its shareholders as of December 13, 2024.
When is the next PMV Pharmaceuticals dividend payment date?
PMV Pharmaceuticals (PMVP) stock does not pay dividends to its shareholders.
What is the beta indicator for PMV Pharmaceuticals?
PMV Pharmaceuticals (PMVP) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.